supplemented with 5% horse serum (Gibco), 0.5 ug/ml hydrocortisone (Sigma-Aldrich), 10 ug/ml insulin (Sigma-Aldrich), and 20 ng/ml epidermal growth factor (Sigma-Aldrich). For MCF10a cells, 0.1 ug/ml cholera endotoxin (Sigma-Aldrich) was also included. The breast cancer cells were cultured in DMEM medium (Invitrogen) supplemented with 10% fetal bovine serum (Gibco). MDA-MB-231 is a metastatic line derived from spontaneous lymph node metastases of MDA-MB-231-luc breast cells.
Viral production and infection
Lentivirus was produced by co-transfection of HEK 293T cells (ATCC) with the lentiviral constructs pVSV-G and psPAX2 (Addgene). Transfections were carried out using Lipofectamine 2000 (Invitrogen). For enforced AF1q expression or shRNA targeting, cells underwent lentiviral transduction and were selected using 1 μg/ml puromycin (Thermo Fisher) as previously described (4) . After antibiotic selection, cells were cultured in complete medium including 1 µg/ml doxycycline (Thermo Fisher) for AF1q or shRNA induction.
Chemo-resistance Assay
Cell cytotoxicity was assessed by measuring the reducing power of live cells. Cells were seeded and then incubated with 100 nM of Doxorubicin (MP Bio) or 100 μM of Etoposide (MP Bio) at 37°C. After 24h, cells were washed with PBS to remove dead cells. Reducing power was assayed using the Prestoblue (Invitrogen) according to the manufacturer's instructions.
Experiments were performed in triplicates with three repeats for each experiment.
Transwell migration assay
The lower side chambers were filled with 750 µL of complete medium. Cells (2.5×10 3 cells
per insert for migration and HMLE 2.5×10 5 and others 2.5×10 4 cells per insert for invasion) were seeded in the upper side chambers with basal medium with 0.1% BSA (MP Bio). Cells were allowed to migrate 16 h for the migration assay and 24 h for the invasion assay. Non-migrated cells were removed with cotton swabs, and migrated cells were fixed with ice-cold methanol and stained with Kwikdiff stain kit (Thermo Scientific). Images were captured using the camera on a Zeiss inverted microscope with magnification x100. Cells that migrated to the lower side of the filter were quantified by manual counting.
Mammosphere assay
Cells were trypsinized to obtain a single cell suspension, and then diluted to a concentration of 
RNA and miRNA extraction and RT-qPCR analysis
The total RNA extracted with mirVana miRNA isolation kit (Invitrogen) was reverse transcribed using High Capacity cDNA Reverse Transcription kits (Applied Biosystems)
according to the manufacturer's instructions. qPCR was performed on an ABI 7500 System miRNAs were detected by RT-qPCR using the TaqMan miRNA Assay. mRNA and miRNA29b expression was normalized to HPRT1 and RNU48, respectively. All samples were run in triplicate and mean value and s.d. were calculated.
Western blot and Cellular fraction
For blots of whole-cell lysates, cells were lysed directly in GLB buffer (2% SDS, 10%
glycerol and 50 mM Tris, pH 6.8), boiled, and separated by electrophoresis on a 4 -12% SDS-PAGE gradient gel. Proteins were transferred to PVDF membrane (Millipore) and blocked in 5%
skim milk (Bio-Rad) in 0.05% PBST. Rabbit monoclonal anti-AF1q antibody was co-developed with Epitomics. Anti-CD44, TCF7 and β-actin monoclonal antibodies were purchased from Cell Signaling Technology, Inc. After the appropriate antibody incubations, an enhanced chemiluminescence (Denville) system was used for developing blots.
Cellular fractionation was performed using the NE-PER™ Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific) according to the manufacturer's instructions. Protein concentration was evaluated in each fraction using a BCA kit (Thermo Scientific) after isolation and then performed Western blotting as described above using AF1q antibody. GAPDH and Histone H3 (Santa Cruz) were used for internal loading control.
Anoikis Assay
Cells were dissociated and plated (2×10 5 cells/well) into a 6-well Ultra-Low Attachment Cluster Dish (Costar) with normal growth media for 24 hours to induce anoikis. Apoptosis was analysed using Dead Cell Apoptosis Kit with Annexin V APC and SYTOX Green (Invitrogen). Apototic cells and dead cells were detected using annexin V expression and SYTOX nucleic acid staining by flow cytometry, respectively. All samples were analyzed triplicate and cells plated normal culture plate were used as a control.
Yeast-2-Hybrid screening
Yeast 2-hybrid screening was performed using the ULTImate Y2HTM system (Hybrigenics Services). Recombination with the N-LexA-bait-C fusion vector pB27 plasmid and AF1q (1-90) generated the yeast bait constructs. The library construction of human thymocytes (CD4+, CD8+) RP1 subcloned into pB27 was screened following the manufacturer's protocols.
Co-immunoprecipitation (Co-IP) assays
MCF10a cells were fractionated and nuclear fractions were incubated with anti-TCF7
antibody on a rocker at 4°C overnight. Immunocomplexes were pulled down by incubating with Protein A-Sepharose (Cell Signaling) for 1 h at 4°C, followed by washing 3 times with ice-cold lysis buffer to eliminate non-specific interactions. Protein A-sepharose-bound immunocomplexes were then resuspended in SDS-PAGE loading buffer, boiled for 10 min, and analyzed by Western blot as described above.
Wnt pathway activity assay
Dual-Luciferase reporter assays were performed using a TOP/FOP reporter system (Milipore).
Briefly 
CD44 promoter luciferase assay
To construct reporter plasmids, 890 bases of a CD44 (-908/-118) promoter fragment were cloned to between XhoI and HindIII sites of the pGL4-Luciferase reporter plasmid (Promega) (5) . Luciferase activity was measured as described above.
Electrophoretic mobility shift assay
The reaction mixtures (10 μl) containing 5 μg of nuclear extract, 1X binding buffer, 50 ng of poly (dI-dC) and 20 ng of Alexa 488-labeled CD44 promoter region probe (5'-CTTTTCCTTTGAGGCCTGCCTCAA-3', IDT) incubate for 30 min at room temperature.
Reaction mixtures containing no nuclear extract were also incubated with labeled probes as negative control samples. Each sample was loaded onto a 6% polyacrylamide gel in 0.5X Tris/Borate/EDTA (TBE) buffer. For the antibody super-shift analysis, 1 μg of antibody was added to the nuclear extracts prior to incubation with the Alexa-488 labeled probe for 30 min. In competition analysis, 100-fold molar excess of the unlabeled double-strand oligonucleotide was added to the reaction mixture prior to the addition of the labeled probe. Samples were electrophoresed until the dye had reached 1 inch from the bottom of the gel and then scanned with the Typhoon 9410 imager (GE Healthcare).
RNA-seq
We used Cuffdiff 24 to perform differential expression testing to detect the differential expressed genes. Genes with q<0.05 were defined to be statistically differentially expressed. 
